UNSPSC 51461539: Passion flower extract

This classification denotes a natural product which US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SY49TH8VUA, the source of which US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 99B54VQS6L, the source of which the Integrated Taxonomic Information System classifies under Taxonomic Serial Number 22219 as a member of Kingdom Plantae, Subkingdom Viridaeplantae, Infrakingdom Streptophyta, Division Tracheophyta, Subdivision Spermatophytina, Infradivision Angiospermae, Class Magnoliopsida, Superorder Rosanae, Order Malpighiales, Family Passifloraceae, Genus Passiflora L., commonly known as PASSIONFLOWER or as here, PASSION FLOWER.

UNSPSC 51461539 Passion flower extract is a Commodity code under which state and local governments procure pharmaceutical ingredients and botanical extracts as components in OTC and prescription formulations. Recent activity shows that state and local cooperative purchasing alliances and individual agencies source these ingredients through multi-source pharmaceutical procurement frameworks that bundle generics, OTC products, and botanical components under unified distribution agreements. The work involves supplying raw pharmaceutical materials and finished-form products to state health departments, Medicaid programs, public health systems, and local government healthcare facilities, with vendors required to maintain cGMP certification, FDA compliance, Drug Supply Chain Security Act (DSCSA) compliance, and established relationships with licensed pharmaceutical wholesalers.

Cooperative purchasing alliances dominate the market. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, posted a Request for Proposal on January 20, 2026 (RFP S1070000015802) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products with a March 26, 2026 response deadline; the contract term runs two years with optional extensions, products must be available by May 15, 2026, and effective awards take effect July 1, 2026. MMCAP contracts serve participating state and local government facilities across Minnesota and Oregon. Vendors must supply products through three authorized wholesalers (AmerisourceBergen Drug Corporation, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC), submit detailed product information including NDC codes and manufacturing locations, maintain commercial general liability of $5,000,000 per occurrence and network security liability of $2,000,000, and agree to a 3 percent administrative fee on contract purchases. Evaluation weights 75 percent on price competitiveness, 10 percent on fixed pricing for the contract term, and the remaining 15 percent split among compliance, EDI capability, and administrative-fee agreement.